Benchling AI debuts alongside major new capabilities for antibody discovery, automated data analysis, and development BOSTON, Oct. 14, 2025 /PRNewswire/ -- Benchling today unveiled major new ...

AI's potential for impact in life sciences is profound. As Anthropic CEO Dario Amodei has said in his Machines of Loving Grace essay, AI could "compress decades of biological progress into just a few ...

SAN FRANCISCO and BOSTON, May 7, 2025 /PRNewswire/ -- Benchling, the R&D platform powering the biotech industry, today announced an expanded collaboration with Moderna. What began with Benchling ...

Leading R&D Cloud for biotech, now valued at $6.1BN, is doubling down on its European presence Benchling's growth is fueled by the rapid rise of biotechnology, one of the world's fastest-growing ...

Sajith Wickramasekara, Benchling’s CEO and co-founder. Eight months after enabling its R&D cloud to support FDA-regulated work done in later stages of biopharma product development, Benchling has ...

Ten years ago, Sajith Wickramasekara dropped out of the Computer Science program at MIT to build something new: a software company that helps life science researchers better organize their lab work.

We spotlight trailblazers in the entrepreneurship world, exploring their groundbreaking ventures, innovative strategies, and the latest trends shaping the business landscape. Fresh new ideas and ...